Multiple Sclerosis Implementation Network (Registry)

Recruiting now

Conditions studied: Multiple Sclerosis

In brief

The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center at Houston (UTHealth Houston), Dell Medical School at The University of Texas at Austin, and Novartis Pharmaceuticals Corporation. The goal of MSIN is to improve Multiple Sclerosis (MS) care, patient health, and quality of life through the development and support of implementation research and clinical practice collaboration. MSIN brings together healthcare teams, people with MS, and research leaders in MS and implementation science (IS) to learn, share, test, implement, and disseminate innovations that improve MS care, patient health, and quality of life. This ClinicalTrials.gov record pertains to the MSIN Patient Registry, which is a comprehensive database that integrates participants' electronic health records from various providers.

Key facts

Study ID

NCT07415824

Run by

The University of Texas Health Science Center, Houston

People needed

2000

Starts

2025-04-28

Expected to finish

2030-12-31

Last updated by the study team

2026-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosed with Multiple Sclerosis
• can speak and understand English comfortably

Where it is running

• Multiple Sclerosis Association of America — Cherry Hill, New Jersey, United States (enrolling)
• The University of Texas at Austin — Austin, Texas, United States (enrolling)
• The University of Texas Health Science Center at Houston (UTHealth Houston) — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.